Where to from here?, page-40

Hi All,

I’ve just read these posts & I can’t see what was written about me in the original one as moderated (by this poster, now on permanent ignore).

No time for this rubbish and I will say, it’s a HC poster’s choices how to spend their valuable time researching & posting on stocks they are invested in. My conscience is clear on this, all my opinions are backed up by related articles or ASX ANNs. I read widely & share what I find here as you all know, they are not just random opinions..

Pity others who spend their time in the negative space, which exists for many. Some just want to destroy what they don’t hold for whatever reason, anyway it’s beyond comprehension for me.

There is a good comparison here in stocks, ACW & PIQ on FA in different indications, & that is only because it has been a big wait for many of us, some a lot longer than myself. Also because both stocks will have Big Pharma interest at this present time. So what if I wanted to give Wisdom a heads up? Because we had this one & many others on ACW board at the time.

For PIQ, it is Janssen who will be owning all this retrospective trial data & more, also validation for us on a huge International clinical trial (4000+ participants for CREDENCE). If indeed there is any need to go on with further phases. Their FDA application success for Invokana which I think the news came through on only 1/10/19 & in this last week things have got busy in the CKD space in the USA.

The last comparison I will make on these 2 stocks, but nothing has changed since last week on FA. A few pips & some are calling it. It’s “White noise”.

It’s unfortunate the way some individuals go about things, but I guess they need to understand they are not going to sway anything in my mind on FA, or stop me posting, some people are a lot stronger than people think & what probably really hurts these kind of individuals is that due to a profession, their research, they possibly may know a whole lot more than them regarding Biotechs & clinical trials, whether they be pre-clinical or not, their sex (yes I’m a female), that shouldn’t matter, It has become evident that mistakes in FA analysis have been made, or if we were stupid & listened at the lows of <1c, That would have been disappointing.

A lot of pre-clinical investment with Big Pharma in clinically unmet needs currently in AD (a clinically unmet need) has resulted in at least 1 huge Pharma deal & a payment of <$23 million to run a phase 1 study & a multi billion $ deal with milestones, there are more, including interest in pre-clinical (ie mice). You would think think what this poster should be doing is looking at those, & spending time researching his own investments, instead of attempting to discredit others. But no. Because some people just don’t get it. Thanks for your support.